Current Challenges for IDO2 as Target in Cancer Immunotherapy

Immune checkpoint inhibitors have revolutionized the clinical approach of untreatable tumors and brought a breath of fresh air in cancer immunotherapy. However, the therapeutic effects of these drugs only cover a minority of patients and alternative immunotherapeutic targets are required. Metabolism...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Immunol
Главные авторы: Mondanelli, Giada, Mandarano, Martina, Belladonna, Maria Laura, Suvieri, Chiara, Pelliccia, Cristina, Bellezza, Guido, Sidoni, Angelo, Carvalho, Agostinho, Grohmann, Ursula, Volpi, Claudia
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021
Предметы:
Immunology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097162/
https://ncbi.nlm.nih.gov/pubmed/33968089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.679953
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы